Introduction
Forming a mechanical boundary against pathogens, antigens, and toxins, the monolayer of intestinal epithelial cells (IECs) represents the human body's largest contact area with the environment (1) . From their early development in the crypt bottom until shedding of aged cells at the villus tip, IECs follow a continuous turnover process (2) (3) (4) . Under physiological conditions, a complex interaction between cytoskeleton rearrangement and tight junction proteins guarantees that the cell shedding itself does not mean a disturbance of epithelial integrity (5) . However, alterations of epithelial integrity may lead to development of gut inflammatory disorders (1, 6) , such as inflammatory bowel diseases (IBDs) (7) . IBDs are associated with marked alterations of IECs, leading to increased tight junction permeability, altered cytoskeletal rearrangement, and induction of epithelial cell death with a subsequent loss of barrier function (1, 6) . In vivo studies in IBD patients demonstrated that loss of IEC integrity even preceded the clinical relapse of disease (8) , suggesting that alteration of barrier function is crucial in the pathogenesis of IBDs. However, the exact IEC intrinsic mechanisms involved in the initiation of barrier dysfunction remain enigmatic.
On a subcellular level, Rho GTPases represent signaling molecules centrally involved in arrangement of cytoskeletal proteins and epithelial cell dynamics (9) (10) (11) (12) (13) . Since their activation preferentially takes place when GTPases are associated with cellular membranes (14, 15) , function of Rho proteins crucially depends on their intracellular localization (16) . Recruitment of small GTPases is governed by prenylation, a posttranslational process consisting of the attachment of hydrophobic isoprenoids to the C-terminal CAAX motif of the protein (17) . In the intestinal epithelium, it has been shown that apoptotic as well as physiological cell extrusion requires Rho-mediated signaling pathways (18, 19) . Moreover, Rho-A/ROCK/Myosin II interaction is known to be important for morphogenesis of the primitive gut tube in Xenopus (20) . However, little is known about regulation of Rho-A signaling in the intestinal epithelium and its impact on gut homeostasis in vivo.
Using gene expression profiling of IECs from inflamed versus uninflamed tissue, we identified altered Rho-A signaling in IBD patients. Although Rho-A was expressed at normal levels, cytosolic accumulation of Rho-A in IECs suggested impaired Rho-A activation via prenylation upon inflammation. Consistently, genetic deletion of Rhoa or Pggt1b (encoding for the prenylationcatalyzing enzyme geranylgeranyltransferase-I [GGTase-I] driving Rho-A activation) in murine IECs impacted on cytoskeleton and cell shedding, resulting in epithelial injury and spontaneous gut inflammation. Our data demonstrate that injury in GGTase-I-information of included patients is summarized in Supplemental Table 1 (supplemental material available online with this article; doi:10.1172/JCI80997DS1). Comparative genomic expression analysis of IECs from inflamed versus uninflamed gut areas of CD patients showed that samples within each group clustered, and we were able to identify 129 genes differing significantly (fold-change ≥ 1.5; P ≤ 0.05) between both groups ( Figure 1A) . Interestingly, gene ontology analyses indicated inflammation-associated downregulation of pathways involved in epithelial cell dynamics and IEC extrusion, such as Rho-A signaling, epithelial adherens junctions, and regulation of actin-based motility by Rho ( Figure 1B) . Notably, pathways involving Rho GTPases other than Rho-A, such as Cdc42 signaling, showed no significant changes (Supplemental Figure  1A) . Although our data implicated a relation between impaired Rho-A function in IECs and inflammation in human IBDs, neither protein nor mRNA expression levels of Rho-A were found to be reduced in IECs from inflamed gut areas of CD or ulcerative deficient epithelium was driven by Rho-A dysfunction and that this phenotype could be successfully reversed by Rho activation. Together, our study highlights for the first time to our knowledge the relevance of functional Rho-A signaling and its regulation via prenylation for maintenance of epithelial integrity. Thus, prenylated Rho-A in epithelium emerges as a therapeutic target in IBDs.
Results
A crucial role of epithelial Rho-A in intestinal inflammation. Intestinal erosions and ulcers caused by epithelial injury represent clinical hallmarks of IBDs, but the underlying pathogenesis of epithelial disruption in the context of gut inflammation is not fully understood. To identify alterations in signaling pathways in intestinal epithelium upon inflammation, we used a heuristic approach and performed gene expression arrays in purified IECs from Crohn's disease patients (CD patients) (array data accessible through NCBI's Gene Expression Omnibus [GEO GSE72780]). Clinical Figure 2B ), and significantly elevated levels of Tnfa ( Figure  3F ) compared with Rhoa fl/fl littermates. Colon tissue turned out to be less affected, and the increased numbers of CD4 + T cells and increased mucosal TNF-α levels in the colon of Rho-A ΔIEC mice did not reach statistical significance as compared with WT animals (Supplemental Figure 2 , C and D). Interestingly, the observed intestinal phenotype of Rho-A ΔIEC mice was not derived from a developmental problem during embryogenesis, since neonates from Rho-A ΔIEC mice appeared to be healthy, showed no reduced body weight, and did not differ from Rhoa fl/fl littermates with regard to intestinal tissue structure (Supplemental Figure 2 , E-G). Our data therefore identified epithelial Rho-A as a key regulator in the maintenance of intestinal homeostasis and epithelial cell architecture. The altered epithelial structure in Rho-A ΔIEC mice was associated with a significantly increased intestinal permeability ( Figure 3G ), suggesting that epithelial Rho-A deficiency leads to impairment of intestinal barrier function. colitis patients (UC patients) compared with uninflamed tissue (Figure 2A and Supplemental Table 2 ). However, while -in IECs of control patients -Rho-A was detected almost exclusively at the plasma membrane, IECs in inflamed areas of gut were characterized by a prominent cytosolic accumulation of Rho-A ( Figure 2B , Supplemental Figure 1 , B and C, and Supplemental Table 3 ), suggesting a predominance of inactive Rho-A in IECs of IBD patients. Similarly, cytosolic Rho-A enrichment upon inflammation could also be confirmed in IECs from dextran sulfate sodium-exposed (DSS-exposed) mice ( Figure 2C and Supplemental Figure 1D ), suggesting a link between dysfunction of epithelial Rho-A and gut inflammation. To further address the functional consequences of impaired epithelial Rho-A, we generated mice with an IEC-specific deletion of Rhoa (Rho-A ΔIEC mice) by crossbreeding mice carrying the LoxP-flanked Rhoa gene (21) with mice expressing Cre-recombinase under the control of the epithelium-specific villin promoter (22) . Lack of Rho-A in IECs resulted in decreased body weight ( Figure 3A ) and spontaneous mucosal inflammation in the small intestine, as indicated by high resolution colonoscopy ( Figure 3B ). Evaluation of inflammatory tissue alteration by histologic scoring confirmed small intestinal pathology in Rho-A ΔIEC mice. In partic- To gain further insights into the signaling mechanisms controlling Pggt1b expression in gut epithelium, epithelial organoids were cultured in the presence of different proinflammatory cytokines. Use of gut organoid technique allowed us to perform our analyses in the absence of extraepithelial factors (24) . Interestingly, exposure to the IBD hallmark cytokine IL-6 (25) resulted in a signifi-Deficient prenylation in the inflamed intestinal epithelium of CD and UC patients. Since impaired Rho-A signaling in IBDs could not be explained by decreased Rho-A expression ( Figure 2A ), we postulated an impaired activation of epithelial Rho-A under inflammatory conditions via prenylation, a posttranslational modification necessary for membrane affinity of this GTPase (23) . Notably, expression analysis of the Rho-A-associated prenylation-catalyzing enzyme GGTase-I indicated significantly diminished protein and mRNA levels in IECs of CD and UC patients during mucosal inflammation ( Figure 4 differenced in Rhoa expression could not be observed when we analyzed total gut tissue (Supplemental Figure 4B ), our data furthermore suggest that regulation of intestinal Rhoa expression specifically occurs within the epithelial compartment. Deficient prenylation within IECs results in alteration of cell shedding and loss of gut homeostasis. To further characterize the impact of prenylation on Rho-A signaling and intestinal inflammation in vivo, we created a mouse line with inducible conditional Pggt1b deficiency in IECs. Breeding of Pggt1b fl/fl mice (26) with villin-Cre-ERT2 mice (22) (tamoxifen induces ERT2-dependent Cre-recombinase expression) led to the generation of Pggt-Iβ TiΔIEC mice, which developed normally and showed no signs of intestinal pathology before tamoxifen treatment (data not shown). Tamoxifen-induced specific deletion of Pggt1b within IECs caused cantly decreased Pggt1b expression in epithelial organoids ( Figure  5A ), suggesting that pathologically increased IL-6 signaling in the inflamed gut of IBD patients contributes to downregulation of Pggt1b expression and subsequent impairment of Rho-A activity in IECs. By comparing IECs in colon and small intestine, we observed contrary expression patterns for Il6 and Pggt1b with high Il6 (Supplemental Figure 4A ) and relatively low Pggt1b expression ( Figure 5B ) in the small intestine. Our data therefore implicate that regional as well as inflammation-induced alteration of prenylation levels in IECs might be augmented by IL-6. Besides relatively low levels of Pggt1b expression, IECs in small intestine could also be characterized by a decreased expression of Rhoa mRNA compared with IECs in colon ( Figure 5B ), making the small intestine potentially more susceptible to Rhoa and Pggt1b inhibition. As regional (Figure 7 , B-E). The colon showed signs of moderate inflammation that did not reach statistical significance, whereas significant marked destruction of the villus-crypt architecture and loss of epithelial integrity could be observed in the small intestine of Pggt-Iβ TiΔIEC mice as compared with floxed control mice ( Figure 7E ). Immunofluorescence and biochemistry analyses of small intestine tissue demonstrated that inflammatory injury of small intestine in Pggt-Iβ TiΔIEC mice went along with a massive infiltration of CD4 + T cells, macrophages, and neutrophils ( Figure 7F ) and significantly increased levels of proinflammatory cytokines, such as IL-1β, IL-6, and TNF-α ( Figure 7G and Supplemental Figure 5D ). Colon tissue of Pggt-Iβ TiΔIEC mice showed only moderate alterations with regard to inflammatory cell infiltration and cytokine production (Supplemental Figure 5 , E an F). To investigate whether deficient prenylation in IECs might compromise the gut barrier, we next subjected mice to FITC-dextran oral gavage. We noted a significantly higher increase of FITC serum levels in Pggt-Iβ TiΔIEC mice as compared with control mice, suggesting a breakdown of intestinal barrier function ( Figure 7H ). Time course studies furthermore indicated that development of epithelial injury and impairment of gut barrier after Pggt1b deletion even preceded induction of proinflammatory cytokine production (Supplemental Figure 6 ). The loss of intestinal barrier function therefore appeared as a primary defect in Pggt-Iβ TiΔIEC mice.
To investigate whether prenylation might be an essential process for epithelial cell survival, we next studied epithelial development in organoids (24) from Pggt-Iβ TiΔIEC mice. Pggt1b deletion impaired the maintenance of complex epithelial organization and resulted in destruction and death of ex vivo cultured and tamoxifen-exposed organoids from Pggt-Iβ TiΔIEC mice ( Figure 8 and Supplemental Figure 7 ), suggesting that GGTase-I activity acts as an epithelial-intrinsic factor controlling cell survival. These data clearly demonstrated that gut epithelial organization and integrity directly depend on prenylation within IECs.
Dysregulation of apoptosis and necroptosis in IECs has been previously described to cause intestinal inflammation via loss of barrier function (4). To investigate whether excessive epithelial cell death might be a key driving factor of the severe phenotype occurring in Pggt-Iβ TiΔIEC mice, we determined whether apoptosis or necroptosis might play an important role. However, neither the additional IEC-specific deletion of Casp8, nor that of the necrop- Figure 8E ), excluding the possibility that cell proliferation arrest is a key underlying mechanism for tissue injury in Pggt-Iβ TiΔIEC mice. Our finding of severe barrier dysfunction in the absence of alterations in key homeostatic mechanisms finally led us to study epithelial cell shedding, a process crucial for the regulation of epithelial turnover in the steady state. Notably, using in vivo confocal microscopy of the gut (5), we observed marked alterations of the monolayer due to the occurrence of epithelial gaps in Pggt-Iβ TiΔIEC mice but not control mice ( Figure 9A ). Under physiological conditions, such gaps are formed by the shedding of epithelial cells and sealed by neighboring cells (3, 5, 27) to avoid breakdown of barrier function. To determine whether barrier function and cell shedding were altered in Pggt-Iβ TiΔIEC mice, as recently observed in IBD patients (8, 28, 29) , we performed in vivo rhodamine leakage assays. These studies revealed an increased passage of topically applied dextran from the lumen to the lamina propria in Pggt-Iβ TiΔIEC Figure 10A ). Cytoskeleton rearrangement was analyzed by kinome array of GGTase-I-deficient IECs.
as compared with control mice ( Figure 9B and Supplemental Figure 9A ). Villus tips in Pggt-Iβ TiΔIEC mice showed marked accumulation of leakage points and appearance of dextran-permeable IECs ( Figure 9C ), suggesting altered epithelial cell integrity. Furthermore, cell shedding was increased in Pggt-Iβ TiΔIEC mice (Supplemental Figure 9B) , consistent with the barrier loss and suggesting shedding alterations as key processes mediating the phenotype of Pggt-Iβ TiΔIEC mice. genes were regulated in IECs of Pggt-Iβ TiΔIEC mice as compared with control mice (fold-change ≥ 2; P ≤ 0.05) ( Figure 11, A and B) . Gene ontology analysis from GGTase-I-deficient IECs implicated an association between GGTase-I prenylation and cell viability/ cell death induction, cytoskeleton rearrangement, and cell morphology ( Figure 11 , C and D, and Supplemental Table 5 ), consistent with our mechanistic observations and previous findings on potential Rho targets (30) . Interestingly, when we compared the gene expression profile in IECs from IBD patients and GGTase-Ideficient IECs, Rho-A signaling could be identified as one of the only 2 pathways significantly regulated in both conditions ( Figure  11E ). Beside Rho-A signaling, only the aryl hydrocarbon receptor (AHR) pathway (31) was regulated in both settings, but it seemed to be of minor functional relevance, since the expression of AHR repressor (AHRR) (32) turned out to be unchanged in IECs from Pggt-Iβ TiΔIEC mice (Supplemental Figure 11 ). Furthermore, Rho-Aand GGTase-I-deficient IECs resembled each other in the accumulation of arrested cell shedding events ( Figure 10 , B and C, and Figure 12 , A and B) and in their inability to form regular organoid structures ( Figure 12C ). Together, these data strongly suggested that impairment of Rho-A signaling represents the pivotal consequence of deficient GGTase-I activity in IECs, relevant for epithelial integrity and IBD pathogenesis.
Phosphorylation of 19 out of 64 cytoskeleton-related proteins was modified, and many of these proteins are known to be involved in Rho-A regulation (Supplemental Figure 10B ). Since cytoskeleton rearrangement and tight junction redistribution represent one of the early events occurring in cell shedding (27) , we hypothesized that cell shedding was arrested in Pggt-Iβ TiΔIEC mice. Hence, we quantified the number of IECs showing redistribution of actin fibers (funnel-like structures, arrested events) versus cells that have been already shed into the lumen (nucleus does not belong to the monolayer, completed events) (Supplemental Figure 10C) . Indeed, the accumulation of arrested (early) versus completed (late) shedding events in GGTase-Iβ-deficient small intestine ( Figure 10C ) indicated an impaired completion of cell extrusion. Accumulated half-shed cells might subsequently impair the normal cytoskeletal mechanisms to seal the resulting gap.
Mucosal inflammation in the absence of GGTase-I is driven by blockade of Rho-A signaling. In order to further analyze the interplay between deficient prenylation, impaired Rho-A signaling, and epithelial injury, we next performed a more profound characterization of molecular alterations in GGTase-Iβ-deficient IECs. Quantitative proteomic and gene expression assays (array data accessible through NCBI's GEO [GSE72781]) revealed that the steady-state levels of 322 proteins and the expression of 725 furthermore pointed to a potential therapeutic applicability of Rho activators for treatment of epithelial-derived gut pathology.
Discussion
Epithelial injury represents an important but not fully understood aspect of IBD pathogenesis (33) . While recent studies have shown that epithelial injury in IBDs can be initiated by mechanisms regulating cell death in IECs, such as apoptosis and necroptosis (34), we here identified a new mechanism of epithelial damage in IBDs induced by impaired Rho-A signaling with subsequent cytoskeletal alterations of IECs and altered cell shedding. Such abnormal cell shedding may cause intestinal erosions and ulcer formation in IBDs and favors impaired barrier function that may clinically precede the development of acute flares in IBD patients (8, (27) (28) (29) .
In the inflamed gut, epithelial-extrinsic mediators, such as proinflammatory cytokines derived from activated lamina propria immune cells (TNF-α, IL-6, and IL-13) (35) (36) (37) , are potent inducers of IEC apoptosis and pathological cell shedding with subsequent impairment of epithelial barrier function (35, (37) (38) (39) (40) . However, an increased occurrence of abnormal intestinal permeability in healthy relatives from IBD patients (41) , and the finding that loss of barrier function in IBDs often preceded the clinical relapse of disease (8, 28), strongly argue against the assumption that IBD-associated epithelial barrier defects rep-In line with this suggestion, GGTase-Iβ-deficient IECs showed a substantial decrease of membrane-bound and an accumulation of cytosolic Rho-A ( Figure 13 , A and B, and Supplemental Figure 12A ), while other small Rho GTPases did not show this profile (Supplemental Figure 12B ). Reduced membrane-localization of Rho-A in IECs of Pggt-Iβ TiΔIEC mice was paralleled by inefficient GTPase activation, resulting in reduced levels of active GTP-bound Rho-A ( Figure 13C ), and decreased phosphorylation of the downstream Rho-A target protein myosin light-chain 2 (MLC2) ( Figure 13D ). Thus, we confirmed that Rho-A activation and signaling is markedly impaired in IECs in the absence of GGTase-I. On a functional level, we wondered whether activation of Rho-A signaling would rescue the intestinal pathology in Pggt-Iβ TiΔIEC mice and, thus, treated these mice with Rho activators. Analysis of Pggt-Iβ TiΔIEC mice exposed to the specific Rho activator CN03 indicated that successful triggering of Rho-A activity in IECs in vivo (Supplemental Figure 12C ) resulted in a significant amelioration of mucosal damage in endoscopy (Figure 14, A and B) , a clear tendency toward decreased histological damage score (P = 0.054) ( Figure 14 noted in the large intestine. This could be due to the compensatory effects of other small GTPases in the large intestine. The identification of these GTPases will require further studies in the future.
Our findings indicate that epithelial integrity, intestinal architecture, and homeostasis critically depend on sufficient prenylation of Rho proteins within IECs. IEC-specific deletion of the enzyme GGTase-I resulted in intestinal disease characterized by accumulation of inactive cytosolic Rho-A, epithelial injury, and mucosal inflammation. Likewise, abrogation of Rho-A in IECs led to marked epithelial alterations and intestinal inflammation. Our findings suggested that impairment of GGTase-I-mediated prenylation in IECs causes accumulation of Np cytosolic Rho-A molecules that are functionally inactive. This subsequently results in impaired regulation of cytoskeleton rearrangement (42) with instability of cell shape and alteration of cell shedding. Accumulation of arrested cell shedding events within the epithelial monolayer finally resulted in loss of barrier function and pathologically increased intestinal permeability. Altered intestinal permeability may subsequently cause chronic intestinal inflammation. Indeed, time-course studies in inducible GGTase-I-deficient mice revealed that altered barrier function precedes mucosal inflammation, suggesting a primary barrier defect in such animals. The potential relevance of these findings for humans was underlined by the observation that significant downregulation of GGTase-I levels and cytosolic Rho-A accumulation was seen in the gut epithelium of IBD patients with active disease. Thus, in addition to the role of Rho-A signaling in cytoskeleton regulation (43) , maintenance of cell shape (44) , and cell migration (45) , Rho-A emerges as a crucial regulator of gut epithelial homeostasis, and this function critically depends on cellular availability of prenylated Rho-A. Our findings indicated that Rho-A signaling is involved in epithelial cell shedding during inflammation. Consistently, inhibi-resent a pure secondary phenomenon of chronic colitis. Instead, epithelial-intrinsic alterations may play a primary role in IBD pathogenesis, and their modulation might open a field for potential therapeutic or preventive interventions. In this context, the here described requirement for sufficient Rho-A prenylation in gut epithelium represents an interesting new aspect, which significantly improves our understanding of intracellular regulation in IECs. In particular, the observation that Pggt1b deletion in ex vivo organoids impaired the maintenance of complex epithelial organization, even in the absence of any immune cell-derived factor, strongly supported the independency of Rho-A signaling cascades from epithelial-extrinsic mediators. On the other hand, the observed regulatory impact of IL-6 on GGTase-Iβ expression clearly demonstrated the high complexity of the interplay between epithelial and epithelial-extrinsic mediators in pathogenesis of IBDs. Our observation that IECs in small intestine of unchallenged WT mice showed as significantly decreased expression of Rhoa mRNA compared with IECs in colon might implicate augmented susceptibility of the small intestine to Rho-A and GGTase-Iβ inhibition. It will therefore be important to investigate in future studies whether levels of epithelial Rho-A expression or activation along the gastrointestinal tract might indeed impact on regional differences in disease manifestations in IBD patients.
The functional relevance of Rho-A and GGTase-I-mediated Rho-A activation for functional integrity of the intestine was highlighted by studies in mice with conditional gene targeting in which deletion of Rhoa or Pggt1b in IECs caused spontaneous chronic intestinal inflammation with accumulation of granulocytes and CD4 + T cells and augmented production of the proinflammatory cytokine TNF-α. The phenotype of these mice was particularly prominent in the small intestine, while little inflammation was (22) . Pggt-Iβ TiΔIEC mice were crossbred with Casp8 fl/fl or Rip3k -/in order to impair apoptosis or necroptosis, respectively. Ethanolic tamoxifen (Sigma-Aldrich) solution was emulsified in sunflower oil and administered for 3 consecutive days by i.p. or intrarectal routes (1 mg/mouse/day). Littermates carrying loxpflanked target genes but not the Cre-recombinase were used as control.
Genotyping was performed by PCR in ear or tail genomic DNA. Animal studies were conducted in a sex-and age-matched manner using littermates for each experiment. Both male and female animals were used at the age of 6-10 weeks. All mice were kept under specific pathogenfree conditions. Except for DSS-induced colitis, animals from different experimental groups were cohoused in every experiment. Mice were routinely screened for pathogens according to Federation for Laboratory Animal Science Associations (FELASA) guidelines. DSS-induced colitis. Colitis was induced in C57BL/6J mice by daily supplementation of drinking water with 2% w/v dextran sulfate sodium (MP Biomedicals) for 7 days (47, 48); DSS was withdrawn on day 7, when animals received normal drinking water. Animals were sacrificed 10 days after starting of the DSS treatment.
Mouse endoscopy. Gut status of mice was monitored by high-resolution mouse video endoscopy as previously described (49) . Mice were anesthetized with 2%-2.5% isoflurane in oxygen during endoscopy. Any colitis was scored basing on the following 5 parameters: thickening of the colon wall, changes in the normal vascular pattern, presence of fibrin, mucosal granularity, and stool consistency. Endoscopic scoring of each parameter was performed (0 to 3), leading to a cumulative score between 0 (no signs of inflammation) and 15 (very severe inflammation) (50) .
tion of the Rho-associated kinase (ROCK), as well as deletion of the Rho-A target MLC kinase (MLCK), has been shown to result in incomplete cell extrusion (27) . Microscopically, ROCK and MLCK inhibition resulted in a predominant appearance of funnel-like structures (arrested shedding events) built up by reorganized actin filaments and tight junction proteins along lateral membranes of shedding cells. However, the final consequence of the accumulation of arrested shedding events has not been considered previously (27) . Such accumulation of epithelial funnel-like structures could also be observed in the intestine of Pggt-Iβ TiΔIEC mice, indicating that redistribution of tight junction proteins takes place, but complete extrusion and resolution of shedding does not occur. Altered cell shedding in the absence of appropriate Rho-A function finally resulted in epithelial instability and loss of barrier function, leading to chronic intestinal inflammation. Hence, our observations confirmed that blockade of cell shedding due to cytoskeleton alterations, mediated by Rho-A among others, is an essential mechanism for disturbances of epithelial integrity.
The oral gavage (4,000 g/mol average molecular weight of FITC-Dextran). Serum was collected 4 hours after gavage, and FITC concentration was determined spectrophotometrically using FITC-Dextran as standard.
In vivo cell shedding. In short (5, 27) , mice were anesthetized by ketamin/xylazin i.p. injection, and the intestine was exteriorized and opened. The mucosa was topically stained with acriflavine (Sigma-Aldrich) and rhodamine-dextran (10,000 g/mol) as luminal dye (Invitrogen). Surgical preparation was pinned up on a coverslide and mounted in a chamber for perfusion of saline solution. Time-sequential Z-stacks images of the villus tip were taken with a confocal microscope (Leica Microsystems).
Quantification of epithelial cell shedding. Epithelial cell shedding was quantified by several techniques. On one side, the cell shedding rate was quantified by the counting of cell shedding events detected by Human samples. Human material was obtained from Department of Medicine I, University Clinic Erlangen, Erlangen, Germany; and Department of Gastroenterology, Humanitas Research Hospital, Milan, Italy. The collection of samples was approved by the local ethical committee and the institutional review board of the University of Erlangen-Nuremberg and Humanitas Research Hospital, and each patient gave written informed consent. Tissue samples were embedded in a convenient matrix for cryosectioning and frozen at -80°C or freshly used for IEC isolation. Clinical information of patients included in our studies is summarized in Supplemental Tables 1-4 .
Intestinal epithelial permeability assessment (FITC-Dextran). Intestinal permeability was assessed in vivo (51) . In brief, Pggt-Iβ TiΔIEC and control mice were deprived of food and water for 4 hours. Afterward, 60 mg FITC-Dextran (Sigma-Aldrich)/100 g body weight was given by BioLegend) . In some cases, direct dye-labeled secondary antibodies were used (1:100, 30 minutes at RT, BioLegend). Actin fiber staining was performed using phalloidin (Invitrogen). In situ cell death detection kit (Roche Diagnostics) was used for detection of TUNEL + cells. For electron microscopy, glutaraldehyde-fixed material was used. After embedding in Epon Araldite, ultrathin sections were cut and analyzed using a Zeiss EM 906. Quantification of IHC. We have exclusively measured the average intensity of GGTase-Iβ or Rap1A signal from epithelium. Using ImageJ software, EpCAM + cells (IECs) were selected, the mean intensity of epithelial GGTase-Iβ or Rap1A signal was detected, and the overall number of IECs was counted based on nuclear staining. The overall number of IECs per image was used for normalization. Using this strategy, we analyzed 2 representative images per experiment in n = 4 experiments. Overall, 8 images from each group (control and inflamed) were included into data interpretation.
The number of CD4 + , F4/80 + , MPO + , and CD8 + cells per field was counted using ImageJ software. A total of 3 different images/sample (×20 objective) were counted, and the average cell number was calculated accordingly.
RNA isolation and quantitative PCR (qPCR) analysis. Total RNA was isolated from tissues or IECs using RNeasy Mini kit (QIAGEN). Synthesis of cDNA was performed using reverse transcriptase. Gene expression was measured by real-time PCR (Bio-Rad) with SYBR Green and QuantiTect primers (QIAGEN). Gene expression was normalized to the housekeeping gene HPRT expression.
Gene expression assay (mouse; array data accessible through through NCBI's GEO [GSE72781]). Gene-chip experiments were performed by the Erlangen University core facility (n = 3 per group). RNA quality was first assessed by Eukaryotic Total RNA Nano (Agilent Technologies), and gene expression was measured using the Affymetrix mouse 430 2.0 chip. For multiple gene array testing, including differential expression analysis, the software package FlexArray (Michal Blazejczyk, Mathieu Miron, and Robert Nadon [2007] , Genome Quebec, Montreal, Canada; http://www.gqinnovationcenter.com/services/ bioinformatics/index.aspx?l=e) was used. GO-based analyses were performed using the online tool Database for Annotation, Visualization, and Integrated Discovery (DAVID) and the platform Ingenuity.
Gene expression assay (human; array data accessible through through NCBI's GEO [GSE72780]). More than 30 samples were collected from the gut of patients suffering from CD or control patients. IECs were isolated from patient specimen as described. RNA was isolated using the RNeasy Lipid Tissue Mini kit according to manufacturer's instructions (QIAGEN). Nine samples were chosen for GeneChip analysis according to the following inclusion criteria: histopathological confirmation of inflammation status, acceptable RNA quality as confirmed by a bioanalyzer, and comparable expression of the epithelial marker villin.
GeneChip analysis. Genome-wide expression analysis was performed in the Genomics core facility of the Institute of Human Genetics of the University Erlangen-Nuremberg using the Affymetrix GeneChip Human Genome U133 Plis 2.0 Arrays. For multiple gene in vivo cell imaging. The number of cell shedding events was normalized by the length of the basal membrane on the individual pictures and the time of image acquisition. A total number of 10 animals were analyzed. On the other hand, we have also counted the number of leakage and "permeable cells" (our terminology for cells with dextran in the cytoplasm) in 2 single in vivo images from each specimen (n = 8 animals). Finally, a similar method was performed in order to quantify the number of arrested versus completed cell shedding events. However, in this case, we took advantage of actin staining with phalloidin, which allowed us to detect the cytoskeleton protein redistribution occurring in early stages of the cell shedding process. We thus quantified the overall cell shedding rate, the distribution of different stages of cell shedding, and the appearance of dextran-permeable cells.
IEC isolation. Murine gut tissues and human surgical specimens were freshly used for IEC isolation. Therefore, tissue was incubated in a solution containing DTT and EDTA (34) . Purification of IECs was performed by Percoll gradient.
Crypt isolation and organoid culture. Small intestine was aseptically isolated, washed, and cut. Intestinal fragments were washed, incubated in chelation buffer (containing EDTA), and vigorously resuspended in order to isolate intestinal crypts. Crypts were embedded in Matrigel (BD Biosciences) on ice and seeded in surface cell culture plates. After polymerization of Matrigel, basal culture medium was added to the culture (24) . The entire medium was changed every 2 days, and organoids were passaged weekly. Organoids were treated in vitro with 0.5 μg/ml tamoxifen; the caspase inhibitor Z-VAD (10 μg/ml) (Bachem) or Necrostatin-1 (30 μM) (Sigma-Aldrich), and cytokines (20 ng/ml).
Quantification of cell viability and death in crypt organoid cultures. We used a cell viability imaging kit (Roche Diagnostics) in order to quantify the death/destruction of organoids after in vitro treatment of organoids with tamoxifen and subsequent deletion of Pggt1b gene. This kit includes 3 different dyes in order to identify nuclei (blue dye), viable cells (green dye), and dead cells (red dye). Identification of dead cells is based on permeability of those cells due to destruction of the cell membrane. Detection of cell viability is based on metabolic activity, which allows the cleavage of the substrate, resulting in green fluorescence. Nuclear staining (blue) enabled normalization of results based on the overall number of detected cells. Quantification of the mean intensity of dead cell signal (red signal) and nuclear signal (blue signal) was performed using ImageJ software.
Histology, IHC, and electron microscopy. Formalin-fixed paraffin-embedded samples were used for H&E staining and histopathological analysis. The score of the histological damage in colon, ileum, and duodenum took into account the 2 parameters epithelial erosion and distorted tissue architecture. Each parameter was scored (none, 0; mild, 1; pronounced, 2; severe, 3), and both results were summed afterward (maximum score of 6). Scoring was performed in a blinded fashion. IHC was performed in cryosections, using TSA Cy3 (Perkin-Elmer). Images were acquired by fluorescence microscopy (Olympus or Leica) or by confocal microscopy (Leica TCS SP5 or Leica TCS SP8). The following primary antibodies were used overnight at 4°C: GGTase-Iβ, 1:100 (catalog sc-18996, Santa Cruz Biotechnology Inc.); Np-Rap1A, 1:100 (catalog sc-1482, Santa Cruz Biotechnology Inc.; for exclusive detection of Np-Rap1A); EpCAM, 1:100 (catalogs 324201 and 118207, BioLegend); MPO, 1:250 (catalog ab9535, Abcam); CD4, 1:200 (catalog 100506, BioLegend); F4/80, 1:100 (catalog 123101, jci.org Volume 126 Number 2 February 2016
Rho-A activation assay. Rho-A activation status was measured by using Rho-A G-LISA Activation Assay (catalog BK214, Cytoskeleton Inc.), following manufacturer's instructions.
Rho activator treatment. Mice were randomly distributed into 2 groups (Pggt-Iβ TiΔIEC ± CN03) and Pggt-Iβ flx littermates were used as controls. Mice were treated with the Rho Activyator II (catalog CN03, Cytoskeleton Inc.) before onset of intestinal disease (oral, 0.3 μg/mouse; intrarectal, 0.5 μg/mouse). Tamoxifen was administered intrarectally. Animals were sacrificed 10 days after starting tamoxifen induction.
Statistics. Significance analysis of normally distributed data was performed using 2-tailed Student's t test. Error bars represent ± SEM. For multiple comparisons, data were analyzed by 1-way ANOVA and LSD post-hoc test (IBM SPSS Statistic 21) . P values of less than 0.05 and 0.001 were considered significant and highly significant.
Study approval. Animal protocols were approved by the Institutional Animal Care and Use Committee of the University of Erlangen. Animal studies were performed in accordance with German law and with approval from Regierung Mittelfranken (Ansbach, Germany). Collection of human samples was approved by Ethics Committee of the Department of Medicine of the Univeristy of Erlangen-Nuremberg (Erlangen, Germany) and Humanitas Research Hospital. Each patient gave written informed consent.
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